What is the role of NGS-based molecular profiling for providing roadmaps suggesting how combination, targeted therapy can produce improved clinical outcomes?

What is the role of NGS-based molecular profiling for providing roadmaps suggesting how combination, targeted therapy can produce improved clinical outcomes?

What is the role of NGS-based molecular profiling for providing roadmaps suggesting how combination, targeted therapy can produce improved clinical outcomes?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jean-Charles Soria, MD

Jean-Charles Soria, MD

Professor of Medicine and Medical Oncology
South-Paris University
Cancer Specialist
Institut Gustave Roussy (IGR)
Paris, France